In early September, Alpha Tau announced that it treated the first patient in its 30-patient US trial. This trial is set to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible resultsResults that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback